Xanomeline and Trospium

Publication Details

CASRN: 131986-45-3; 47608-32-2

SID: 388765364; 433990217

Drug Levels and Effects

Summary of Use during Lactation

No information is available on the clinical use of xanomeline or trospium during breastfeeding. Trospium is unlikely to enter milk because it is a charged molecule. If a mother requires xanomeline and trospium, it is not a reason to discontinue breastfeeding. Monitor the infant for vomiting, diarrhea, abnormal movements and adequate weight gain.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Substance Identification

Substance Name

Xanomeline and Trospium

CAS Registry Number

131986-45-3; 47608-32-2

Drug Class

Breast Feeding

Lactation

Milk, Human

Antipsychotic Agents

Parasympathomimetics

Psychotropic Drugs

Muscarinic Agonists

Parasympatholytics

Muscarinic Antagonists

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.